Last reviewed · How we verify

NCT05220475

A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent

Status unknown NA Last updated 2 February 2022
What this trial tests

NA trial testing fully covered self-expandable metal stent with an anchoring external plastic stent in Malignant Biliary Obstruction in 108 participants. Status unknown.

Timeline
25 October 2021
Primary endpoint
24 October 2023
24 October 2024

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment108
Start date25 October 2021
Primary completion24 October 2023
Estimated completion24 October 2024
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

19 and older, any sex, with Malignant Biliary Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multi-center, randomized controlled study fc-SEMS with anchoring plastic stent vs uc-SEMS in malignant biliary obstruction

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prevention of stent migration of covered self-expandable metal stents in distal malignant biliary obstruction: a review of literature.
    Chun JW, Paik WH, Woo SM, Choi JH, et al · · 2025 · PMID 40584149 · DOI 10.1093/gastro/goaf058

Verify or expand the search:

Other recruiting trials for Malignant Biliary Obstruction

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05220475.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing